Are there any side effects or risks associated with B12 injections for fatigue
After 40 weeks, tirzepatide significantly outperformed placebo in both glycemic control and weight loss
this generally results from genetic variability in the enzymes needed to produce and/or regenerate it 2
3 Although no studies have prospectively stratified patients by baseline A1C in evaluation of the A1C-lowering efficacy of a DPP-4 inhibitor or SGLT2 inhibitor, post-hoc subgroup analyses have shown that the efficacy of SGLT2 inhibitors is greater than that of DPP-4 inhibitors among patients with higher baseline A1C ( 8-8.5%), while patients with baseline A1C at the lower end of the spectrum ( 30 mL/min and clinical CV disease according to Diabetes Canada
GHK-Cu, also known as Copper Tripeptide-1 or glycyl-L-histidyl-L-lysine, is a tiny peptide, with just three amino acids (glycine, histidine, and lysine) attached to a copper ion, making it a copper-binding peptide